Outcome measures for use in trials of paediatric otorrhoea: A systematic review

Elliot Heward1, James Dempsey2, John Molloy1

  • 1Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, UK; Royal Manchester Children's Hospital, Manchester University Hospitals NHS Foundation Trust, UK.

Insights

This review found that "otorrhoea cessation" is the primary outcome in most studies of paediatric ear infections. Future research should standardize this measure for better comparison of treatments for children with ear discharge.

Area of Science:

  • Otolaryngology
  • Pediatric Medicine
  • Evidence-Based Medicine

Background:

  • Paediatric otorrhoea (PO) involves middle ear infections with tympanic membrane perforation and ear discharge in children.
  • Prolonged PO can lead to hearing loss and developmental delays.
  • Current management is variable due to a weak evidence base, highlighting the need for standardized outcome reporting.

Approach:

  • A systematic review was conducted following PRISMA guidelines, searching EMBASE, MEDLINE, and Cochrane databases from January 1995 to May 2023.
  • Included randomized controlled trials and study protocols for children and young people (CYP) with PO.
  • Risk of bias was assessed using Cochrane's tool.

Key Points:

  • Six studies were included from 377 identified papers.
  • The primary outcome in five studies was otorrhoea cessation, measured by time to cessation and proportion recovered.
  • Two applicable measurement instruments were identified: Otitis Media-6 Questionnaire and the Institute for Medical Technology Assessment Productivity Cost Questionnaire.

Conclusions:

  • Standardizing "time to cessation of otorrhoea" as the primary outcome in future studies is recommended for homogeneity and comparison.
  • Further research is necessary to confirm if this outcome is most meaningful to children and caregivers.
Abstract